Germany Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

Description

List of Tables

GlobalData's "Germany Oncology Market Outlook to 2033" is a comprehensive databook report, covering key market data on the Germany Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests, ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The Germany Oncology Market report provides key information and data on -

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2024 company share data for Oncology Market.
Global corporate-level profiles of key companies operating within the Germany Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Germany Oncology is segmented as follows -

Colorectal Cancer Screening Tests
EGFR Tests
KRAS Tests
HER2 Tests
BRCA Tests
ALK Tests
BRAF Tests
BCR-ABL Tests
PD-L1 Tests

Reasons to Buy

The Germany Oncology Market report helps you to develop -

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Product Code: GDME25622CCDB

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Oncology Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Oncology Market, Germany

3.1 Oncology Market, Germany, Revenue ($m), 2018-2033
- 3.1.1 ALK Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
- 3.1.2 BCR-ABL Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
- 3.1.3 BRAF Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
- 3.1.4 BRCA Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
- 3.1.5 Colorectal Cancer Screening Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
- 3.1.6 EGFR Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
- 3.1.7 HER2 Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
- 3.1.8 KRAS Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
3.2 Oncology Market, Germany, Volume (Units), 2018-2033
- 3.2.1 ALK Tests Market, Germany, Volume (Units), by Segment, 2018-2033
- 3.2.2 BCR-ABL Tests Market, Germany, Volume (Units), by Segment, 2018-2033
- 3.2.3 BRAF Tests Market, Germany, Volume (Units), by Segment, 2018-2033
- 3.2.4 BRCA Tests Market, Germany, Volume (Units), by Segment, 2018-2033
- 3.2.5 Colorectal Cancer Screening Tests Market, Germany, Volume (Units), by Segment, 2018-2033
- 3.2.6 EGFR Tests Market, Germany, Volume (Units), by Segment, 2018-2033
- 3.2.7 HER2 Tests Market, Germany, Volume (Units), by Segment, 2018-2033
- 3.2.8 KRAS Tests Market, Germany, Volume (Units), by Segment, 2018-2033
3.3 Oncology Market, Germany, Average Price ($) , 2018-2033
3.4 Oncology Market, Germany, Company Share by Revenue ($m), 2024

4 Overview of Key Companies in Germany, Oncology Market

4.1 F. Hoffmann-La Roche Ltd
- 4.1.1 Company Overview
4.2 Agilent Technologies Inc
- 4.2.1 Company Overview
4.3 Qiagen NV
- 4.3.1 Company Overview
4.4 Abbott Laboratories
- 4.4.1 Company Overview
4.5 Danaher Corp
- 4.5.1 Company Overview
4.6 Eiken Chemical Co Ltd
- 4.6.1 Company Overview
4.7 Amoy Diagnostics Co Ltd
- 4.7.1 Company Overview
4.8 ZytoVision GmbH
- 4.8.1 Company Overview
4.9 BioGenex Laboratories Inc
- 4.9.1 Company Overview
4.10 SENTINEL CH SpA
- 4.9.1 Company Overview

5 Oncology Market Pipeline Products

6 Financial Deals Landscape

6.1 Debt Offerings
- 6.1.1 Merck KGaA Raises USD890.2 Million in Public Offering of 3.875% Bonds Due 2054
6.2 Partnerships
- 6.2.1 Life Technologies Enters into Co-Development Agreement with Thermo Fisher Scientific
- 6.2.2 EDX Medical Enters into Distribution Agreement with miRdetect
- 6.2.3 A. Menarini Diagnostics Enters into Distribution Agreement with Nucleix
6.3 Venture Financing
- 6.3.1 Heidelberg Epignostix Secures USD4.6 Million in Seed Funding

7 Recent Developments

7.1 Corporate Communications
- 7.1.1 Mar 03, 2025: AI Diagnostic Platform Improves Early Detection of Skin Cancer
7.2 Other Significant Developments
- 7.2.1 May 19, 2025: Medicare Boosts Reimbursement for Oncocyte's Flagship Technology
- 7.2.2 Mar 10, 2025: Longevity Life Advisors Launches CancerEDGE: A Program Offering Advanced Cancer Genomics and Precision Health Services
7.3 Product News
- 7.3.1 Mar 03, 2025: AI Diagnostic Platform Improves Early Detection of Skin Cancer
- 7.3.2 Nov 11, 2024: Report Published by Research Journal, Germany's Springer Concluded that TruScreen Cervical Cancer Screening Results were Comparable and Better than conventional LBC
- 7.3.3 Oct 17, 2024: Medigene Presents UniTope and TraCR a Universal Detection System for 3S Recombinant TCRs at ASGCT 2024
- 7.3.4 Jul 15, 2024: Peptomyc S.L. Expands Patent Portfolio with European and Indian Patent Grant for its Methods and Composition for the Treatment of Cancer
7.4 Strategy And Business Planning
- 7.4.1 Apr 22, 2025: ConcertAI Signs Strategic Agreement With Bayer
- 7.4.2 Mar 04, 2025: Tower Health, Siemens Healthineers Launch 10-Year Value Partnership to Advance Precision Imaging and Patient Care
- 7.4.3 Dec 05, 2024: IVDR-Certified FISH Probe Portfolio Expands to 95 Probes
- 7.4.4 Nov 26, 2024: Siemens Healthineers and The Ohio State Wexner Medical Center Expand Existing Strategic Relationship

8 Appendix

8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer

Product Code: GDME25622CCDB

List of Table

List of Tables

Table 1: Oncology Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 2: ALK Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 3: BCR-ABL Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 4: BRAF Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 5: BRCA Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 6: Colorectal Cancer Screening Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 7: EGFR Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 8: HER2 Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 9: KRAS Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 10: Oncology Market, Germany, Volume (Units), 2018-2033
Table 11: ALK Tests Market, Germany, Volume (Units), 2018-2033
Table 12: BCR-ABL Tests Market, Germany, Volume (Units), 2018-2033
Table 13: BRAF Tests Market, Germany, Volume (Units), 2018-2033
Table 14: BRCA Tests Market, Germany, Volume (Units), 2018-2033
Table 15: Colorectal Cancer Screening Tests Market, Germany, Volume (Units), 2018-2033
Table 16: EGFR Tests Market, Germany, Volume (Units), 2018-2033
Table 17: HER2 Tests Market, Germany, Volume (Units), 2018-2033
Table 18: KRAS Tests Market, Germany, Volume (Units), 2018-2033
Table 19: Oncology Market, Germany, Average Price ($), 2018-2033
Table 20: Oncology Market, Germany, Company Share by Revenue ($m), 2024
Table 21: Oncology Market Pipeline Products
Table 22: Merck KGaA Raises USD890.2 Million in Public Offering of 3.875% Bonds Due 2054
Table 23: Life Technologies Enters into Co-Development Agreement with Thermo Fisher Scientific
Table 24: EDX Medical Enters into Distribution Agreement with miRdetect
Table 25: A. Menarini Diagnostics Enters into Distribution Agreement with Nucleix
Table 26: Heidelberg Epignostix Secures USD4.6 Million in Seed Funding
Table 27: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figure

List of Figures

Figure 1: Oncology Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 2: ALK Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 3: BCR-ABL Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 4: BRAF Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 5: BRCA Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 6: Colorectal Cancer Screening Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 7: EGFR Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 8: HER2 Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 9: KRAS Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 10: Oncology Market, Germany, Volume (Units), 2018-2033
Figure 11: ALK Tests Market, Germany, Volume (Units), 2018-2033
Figure 12: BCR-ABL Tests Market, Germany, Volume (Units), 2018-2033
Figure 13: BRAF Tests Market, Germany, Volume (Units), 2018-2033
Figure 14: BRCA Tests Market, Germany, Volume (Units), 2018-2033
Figure 15: Colorectal Cancer Screening Tests Market, Germany, Volume (Units), 2018-2033
Figure 16: EGFR Tests Market, Germany, Volume (Units), 2018-2033
Figure 17: HER2 Tests Market, Germany, Volume (Units), 2018-2033
Figure 18: KRAS Tests Market, Germany, Volume (Units), 2018-2033
Figure 19: Oncology Market, Germany, Company Share (%), 2024